User profiles for PA Brogan
Paul BroganUniversity College London Verified email at ucl.ac.uk Cited by 15328 |
Management of Kawasaki disease
Kawasaki disease (KD) is an acute self-limiting inflammatory disorder, associated with
vasculitis, affecting predominantly medium-sized arteries, particularly the coronary arteries. In …
vasculitis, affecting predominantly medium-sized arteries, particularly the coronary arteries. In …
Classification criteria for autoinflammatory recurrent fevers
…, K Barron, E Ben-Cherit, PA Brogan… - Annals of the …, 2019 - ard.bmj.com
Background Different diagnostic and classification criteria are available for hereditary
recurrent fevers (HRF)—familial Mediterranean fever (FMF), tumour necrosis factor receptor-…
recurrent fevers (HRF)—familial Mediterranean fever (FMF), tumour necrosis factor receptor-…
Recommendations for the management of autoinflammatory diseases
<p>Autoinflammatory diseases are characterised by fever and systemic inflammation, with
potentially serious complications. Owing to the rarity of these diseases, evidence-based …
potentially serious complications. Owing to the rarity of these diseases, evidence-based …
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Adenosine deaminases acting on RNA (ADARs) catalyze the hydrolytic deamination of
adenosine to inosine in double-stranded RNA (dsRNA) and thereby potentially alter the …
adenosine to inosine in double-stranded RNA (dsRNA) and thereby potentially alter the …
[HTML][HTML] JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
BACKGROUND. Monogenic IFN–mediated autoinflammatory diseases present in infancy with
systemic inflammation, an IFN response gene signature, inflammatory organ damage, and …
systemic inflammation, an IFN response gene signature, inflammatory organ damage, and …
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
… of Pittsburgh (GA), University of Pittsburgh, PA; Hacettepe University Child Neurology (BA), …
Brogan, PhD … Brogan has received consultancy fees from Roche and Novartis. R. Kneen, G. …
Brogan, PhD … Brogan has received consultancy fees from Roche and Novartis. R. Kneen, G. …
Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research
This article proposes a clinical guideline for the diagnosis and treatment of Kawasaki disease
in the UK based on the best available evidence to date, and highlights areas of practice …
in the UK based on the best available evidence to date, and highlights areas of practice …
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international …
Objective To evaluate the genetic findings, demographic features and clinical presentation
of tumour necrosis factor receptor-associated autoinflammatory syndrome (TRAPS) in …
of tumour necrosis factor receptor-associated autoinflammatory syndrome (TRAPS) in …
Endothelial and platelet microparticles in vasculitis of the young
Objective Microparticles are released from endothelial cells in response to a variety of
injurious stimuli and recently have been shown to be increased in a number of diseases …
injurious stimuli and recently have been shown to be increased in a number of diseases …
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
…, RP Naden, JWJ Bijlsma, PA Brogan… - Annals of the …, 2017 - ard.bmj.com
Objectives To develop a Glucocorticoid Toxicity Index (GTI) to assess glucocorticoid (GC)-related
morbidity and GC-sparing ability of other therapies. Methods Nineteen experts on GC …
morbidity and GC-sparing ability of other therapies. Methods Nineteen experts on GC …